Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8806

1.

Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal.

Dulal S, Paudel BD, Neupane P, Shah A, Acharya B, Poudyal BS, Shilpakar R, Wood LA.

J Glob Oncol. 2019 Apr;(5):1-6. doi: 10.1200/JGO.18.00245.

PMID:
31013182
2.

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.

Weston M, Kaserer T, Wu A, Mouravlev A, Carpenter JC, Snowball A, Knauss S, von Schimmelmann M, During MJ, Lignani G, Schorge S, Young D, Kullmann DM, Lieb A.

Sci Adv. 2019 Apr 17;5(4):eaaw1567. doi: 10.1126/sciadv.aaw1567. eCollection 2019 Apr.

3.

Pharmacological Prevention of Postoperative Delirium: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Liu Y, Li XJ, Liang Y, Kang Y.

Evid Based Complement Alternat Med. 2019 Mar 14;2019:9607129. doi: 10.1155/2019/9607129. eCollection 2019. Review.

4.

Blonanserin ameliorates social deficit through dopamine-D3 receptor antagonism in mice administered phencyclidine as an animal model of schizophrenia.

Takeuchi S, Hida H, Uchida M, Naruse R, Yoshimi A, Kitagaki S, Ozaki N, Noda Y.

Neurochem Int. 2019 Apr 15. pii: S0197-0186(19)30111-1. doi: 10.1016/j.neuint.2019.04.008. [Epub ahead of print]

PMID:
30998952
5.

The unmasking of hidden severe hyponatremia after long-term combination therapy in exacerbated bipolar patients: a case series.

Fabrazzo M, Fuschillo A, Perris F, Catapano F.

Int Clin Psychopharmacol. 2019 Apr 15. doi: 10.1097/YIC.0000000000000265. [Epub ahead of print]

PMID:
30998596
6.

Letter to editor regarding "comparison of efficacy of haloperidol and olanzapine in the treatment of delirium".

Kumar P, Khurana H, Kumar A, Sethi S.

Indian J Psychiatry. 2019 Mar-Apr;61(2):218-219. doi: 10.4103/psychiatry.IndianJPsychiatry_85_18. No abstract available.

7.

[Fangji Dihuang Decoction formula syndrome and Fengyin Decoction formula syndrome:application in stroke and mental disorders].

Xiong XJ.

Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(3):602-607. doi: 10.19540/j.cnki.cjcmm.20181128.004. Chinese.

PMID:
30989929
8.

Neuroprotective effects of the second generation antipsychotics.

Chen AT, Nasrallah HA.

Schizophr Res. 2019 Apr 11. pii: S0920-9964(19)30134-3. doi: 10.1016/j.schres.2019.04.009. [Epub ahead of print] Review.

PMID:
30982644
9.

Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.

Veselinović T, Scharpenberg M, Heinze M, Cordes J, Mühlbauer B, Juckel G, Habel U, Rüther E, Timm J, Gründer G; NeSSy Study Group.

Eur Neuropsychopharmacol. 2019 Apr 10. pii: S0924-977X(19)30202-0. doi: 10.1016/j.euroneuro.2019.03.014. [Epub ahead of print]

PMID:
30981585
10.

Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life.

Wu TH, Chiu CC, Chen PY, Huang MC, Chen CH, Shen WW, Lu ML.

Psychiatry Res. 2019 Mar 6;276:1-5. doi: 10.1016/j.psychres.2019.03.007. [Epub ahead of print]

PMID:
30981095
11.

Chronic Antipsychotic Treatment Modulates Aromatase (CYP19A1) Expression in the Male Rat Brain.

Bogus K, Pałasz A, Suszka-Świtek A, Worthington JJ, Krzystanek M, Wiaderkiewicz R.

J Mol Neurosci. 2019 Apr 9. doi: 10.1007/s12031-019-01307-x. [Epub ahead of print]

PMID:
30968339
12.

Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment.

Wąsik A, Białoń M, Żarnowska M, Antkiewicz-Michaluk L.

Pharmacol Biochem Behav. 2019 Apr 6;181:17-27. doi: 10.1016/j.pbb.2019.04.002. [Epub ahead of print]

PMID:
30965047
13.

Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.

Keramatian K, Chakrabarty T, Yatham LN.

CNS Drugs. 2019 Apr 8. doi: 10.1007/s40263-019-00629-z. [Epub ahead of print]

PMID:
30963507
14.

Low-dose of olanzapine has ameliorating effects on cancer-related anorexia.

Okamoto H, Shono K, Nozaki-Taguchi N.

Cancer Manag Res. 2019 Mar 19;11:2233-2239. doi: 10.2147/CMAR.S191330. eCollection 2019.

15.

Olanzapine induced autophagy through suppression of NF-κB activation in human glioma cells.

Zhu Y, Zhao YF, Liu RS, Xiong YJ, Shen X, Wang Y, Liang ZQ.

CNS Neurosci Ther. 2019 Apr 7. doi: 10.1111/cns.13127. [Epub ahead of print]

PMID:
30955240
16.

Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder.

Brunkhorst-Kanaan N, Klatt-Schreiner K, Hackel J, Schröter K, Trautmann S, Hahnefeld L, Wicker S, Reif A, Thomas D, Geisslinger G, Kittel-Schneider S, Tegeder I.

Metabolism. 2019 Apr 4. pii: S0026-0495(19)30068-X. doi: 10.1016/j.metabol.2019.04.002. [Epub ahead of print]

PMID:
30954559
17.

Insulin Resistance-Related Proteins Are Overexpressed in Patients and Rats Treated With Olanzapine and Are Reverted by Pueraria in the Rat Model.

Yang N, Li S, Liu S, Lv Y, Yu L, Deng Y, Li H, Fang M, Huo Y, Li W, Peng S.

J Clin Psychopharmacol. 2019 May/Jun;39(3):214-219. doi: 10.1097/JCP.0000000000001028.

PMID:
30946280
18.

Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study.

Celio L, Saibene G, Lepori S, Festinese F, Niger M, Raspagliesi F, Lorusso D.

Tumori. 2019 Apr 4:300891619839301. doi: 10.1177/0300891619839301. [Epub ahead of print]

PMID:
30945623
19.

Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia?

Osimo EF, Goujon MJ, Perez J, Murray GK.

BMJ Case Rep. 2019 Mar 31;12(3). pii: e228573. doi: 10.1136/bcr-2018-228573.

PMID:
30936353
20.

Intractable acute ischaemic priapism occurring secondary to newly commenced olanzapine.

Farag M, Goad J, Temelcos C.

BMJ Case Rep. 2019 Mar 31;12(3). pii: e227466. doi: 10.1136/bcr-2018-227466.

PMID:
30936333

Supplemental Content

Loading ...
Support Center